1-21841723-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.9194-50G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.647 in 1,609,232 control chromosomes in the GnomAD database, including 338,829 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.62 ( 29305 hom., cov: 32)
Exomes 𝑓: 0.65 ( 309524 hom. )

Consequence

HSPG2
NM_005529.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.104

Publications

15 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-21841723-C-T is Benign according to our data. Variant chr1-21841723-C-T is described in ClinVar as [Benign]. Clinvar id is 1231634.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.798 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPG2NM_005529.7 linkc.9194-50G>A intron_variant Intron 69 of 96 ENST00000374695.8 NP_005520.4 P98160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPG2ENST00000374695.8 linkc.9194-50G>A intron_variant Intron 69 of 96 1 NM_005529.7 ENSP00000363827.3 P98160

Frequencies

GnomAD3 genomes
AF:
0.616
AC:
93525
AN:
151872
Hom.:
29274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.505
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.593
Gnomad ASJ
AF:
0.732
Gnomad EAS
AF:
0.819
Gnomad SAS
AF:
0.613
Gnomad FIN
AF:
0.693
Gnomad MID
AF:
0.709
Gnomad NFE
AF:
0.656
Gnomad OTH
AF:
0.625
GnomAD2 exomes
AF:
0.652
AC:
161199
AN:
247280
AF XY:
0.653
show subpopulations
Gnomad AFR exome
AF:
0.501
Gnomad AMR exome
AF:
0.617
Gnomad ASJ exome
AF:
0.718
Gnomad EAS exome
AF:
0.815
Gnomad FIN exome
AF:
0.691
Gnomad NFE exome
AF:
0.658
Gnomad OTH exome
AF:
0.646
GnomAD4 exome
AF:
0.650
AC:
947649
AN:
1457242
Hom.:
309524
Cov.:
34
AF XY:
0.650
AC XY:
471097
AN XY:
724932
show subpopulations
African (AFR)
AF:
0.502
AC:
16774
AN:
33396
American (AMR)
AF:
0.614
AC:
27289
AN:
44416
Ashkenazi Jewish (ASJ)
AF:
0.719
AC:
18784
AN:
26122
East Asian (EAS)
AF:
0.835
AC:
33112
AN:
39664
South Asian (SAS)
AF:
0.595
AC:
51116
AN:
85950
European-Finnish (FIN)
AF:
0.685
AC:
36271
AN:
52958
Middle Eastern (MID)
AF:
0.671
AC:
3513
AN:
5238
European-Non Finnish (NFE)
AF:
0.650
AC:
721323
AN:
1109264
Other (OTH)
AF:
0.655
AC:
39467
AN:
60234
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
19224
38449
57673
76898
96122
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18892
37784
56676
75568
94460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.616
AC:
93610
AN:
151990
Hom.:
29305
Cov.:
32
AF XY:
0.619
AC XY:
45946
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.506
AC:
20953
AN:
41426
American (AMR)
AF:
0.593
AC:
9063
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.732
AC:
2543
AN:
3472
East Asian (EAS)
AF:
0.819
AC:
4225
AN:
5158
South Asian (SAS)
AF:
0.612
AC:
2939
AN:
4806
European-Finnish (FIN)
AF:
0.693
AC:
7324
AN:
10572
Middle Eastern (MID)
AF:
0.707
AC:
208
AN:
294
European-Non Finnish (NFE)
AF:
0.656
AC:
44607
AN:
67952
Other (OTH)
AF:
0.627
AC:
1323
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1839
3678
5516
7355
9194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.648
Hom.:
36500
Bravo
AF:
0.609
Asia WGS
AF:
0.734
AC:
2548
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.8
DANN
Benign
0.76
PhyloP100
-0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7556412; hg19: chr1-22168216; API